Herpes Simplex Labialis
📧 Sign up to get email alerts when something new happens for Herpes Simplex Labialis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2017-01-10FDA Approved: ABREVA — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for ABREVA (docosanol) submitted by Haleon US Holdings LLC.